Publications by authors named "Elizabeth Claire Elson"
Article Synopsis
- * A retrospective analysis of inhaled tobramycin (iTOB) prescriptions over six years (2016-2021) was conducted at Children's Mercy Kansas City, showing a decline in new prescriptions for both PA infections and chronic infections after the approval of ETI.
- * The decrease in iTOB prescriptions may be due to better infection management protocols, the positive effects of ETI on lung
Aztreonam Lysine Inhalation Solution in Cystic Fibrosis.
Clin Med Insights Circ Respir Pulm Med
April 2019
Patients with cystic fibrosis (CF) develop pulmonary disease secondary to airway infection and dysregulated inflammation. Therapeutic innovations such as nebulized antimicrobial therapy targeting specific pathogens have resulted in improvements in quality of life and life expectancy. Aztreonam lysine for inhalation (AZLI) solution was initially approved to improve respiratory symptoms in CF patients with (PA) in 2010 by the Food and Drug Administration.
View Article and Find Full Text PDF